Ovarian Epithelial Cancers: A Pathological Study of 164 Cases

Ovarian Epithelial Cancers: A Pathological Study of 164 Cases

Background: Foremost, the diagnosis of ovarian carcinoma is light microscopic in nature. However high-graded tumors and some equivocal cases may require contemporary tests.Objectives: To examine ovarian carcinoma types in Duhok-Iraq using morphology and available immunohistochemical panels.Materials...

Full description

Saved in:

Bibliographic Details
Main Authors:	Intisar Pity, Ghasaq Kareem, Dildar Musa, Abdulkareem Sulaiman, Shang Salih Amedi, Hayam Rasoul, Yasmine Abdalwahab, Dani Hayder
Format:	Article
Language:	English
Published:	University of Anbar 2024-12-01
Series:	Al-Anbar Medical Journal
Subjects:	primary ovarian carcinoma epithelial ovarian cancer metastatic ovarian cancer immunohistochemistry
Online Access:	https://amj.uoanbar.edu.iq/article_184658_30c46d2d184fd64cb8d9b34383196ffa.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Analysis of the level of expression of pancytokeratins in epithelial and granulocellular tumors of the ovaries.
by: O. A. Savchenko, et al.
Published: (2018-06-01)

The relationship between HYDIN and fallopian tubal cilia loss in patients with epithelial ovarian cancer
by: Yuanli Guo, et al.
Published: (2025-01-01)

RETRACTED ARTICLE: SLFN5 promotes reversible epithelial and mesenchymal transformation in ovarian cancer
by: Qiao Ping Xu, et al.
Published: (2023-02-01)

Transcription factor A, mitochondrial promotes lymph node metastasis and lymphangiogenesis in epithelial ovarian carcinoma
by: Wubuli Reziwanguli, et al.
Published: (2025-02-01)

PARP Inhibitors in the Treatment of Ovarian Cancer
by: Andrzej Paweł Zuzak, et al.
Published: (2025-02-01)

Epigenetic editing of BRCA1 promoter increases cisplatin and olaparib sensitivity of ovarian cancer cells
by: Wanhong He, et al.
Published: (2024-12-01)

Cervical adenocarcinoma presenting as an ovarian torsion
by: M. Mvula, et al.
Published: (2024-12-01)

Analysis of the level of expression of pancytokeratins in epithelial and granulocellular tumors of the ovaries
by: Savchenko O.A., et al.
Published: (2018-06-01)

Exploiting Cancer Dormancy Signaling Mechanisms in Epithelial Ovarian Cancer Through Spheroid and Organoid Analysis
by: Emily J. Tomas, et al.
Published: (2025-01-01)

Utilization of immunohistochemistry in gynecologic tumors: An expert review
by: Arielle H. Katcher, et al.
Published: (2024-12-01)

Adjuvant Chemotherapy in Patients with Low-Risk Epithelial Ovarian Cancer: A Taiwanese Cohort Study
by: Yuan-Ting C. Lo, et al.
Published: (2023-04-01)

Development and validation of a nomogram to predict recurrence in epithelial ovarian cancer using complete blood count and lipid profiles
by: Xi Tang, et al.
Published: (2025-02-01)

Bevacizumab as a mitigating factor for the impact of high systemic immune-inflammation index on chemorefractory in advanced epithelial ovarian cancer
by: Yan-Ping Fu, et al.
Published: (2024-11-01)

Management tactics for patients suffering from borderline ovarian tumors in their reproductive years: in the wake of domestic and international guidelines
by: Vladlena M. Pernai, et al.
Published: (2024-09-01)

KAT2B inhibits proliferation and invasion via inactivating TGF-β/Smad3 pathway-medicated autophagy and EMT in epithelial ovarian cancer
by: Yuqin Yao, et al.
Published: (2025-01-01)

Effect of ubiquitin-specific proteinase 43 on ovarian serous adenocarcinoma and its clinical significance
by: Qin Li, et al.
Published: (2024-12-01)

Survival outcomes of lymph node dissection in early-stage epithelial ovarian cancer: identifying suitable candidates
by: Huan Wang, et al.
Published: (2024-11-01)

Editorial: Advances toward improved understanding and treatment of uncommon ovarian cancer types and subtypes
by: Robert L. Hollis, et al.
Published: (2024-12-01)

A case of ovarian mesothelioma with VHL mutation diagnosed by immunohistochemistry and literature review
by: Ye Yao, et al.
Published: (2024-11-01)

Corrigendum: SERPIND1 affects the malignant biological behavior of epithelial ovarian cancer via the PI3K/AKT pathway: a mechanistic study
by: Qian Guo, et al.
Published: (2024-12-01)

Status of and Challenges in Therapy of Mucinous Ovarian Cancer Associated with Pseudomyxoma Peritonei Syndrome: Review of Current Options and Future Treatment Trends
by: George Pariza, et al.
Published: (2024-10-01)

Circulating tumor DNA detection improves relapse prediction in epithelial ovarian cancer
by: Ying Zhang, et al.
Published: (2024-12-01)

Whole exome sequencing-based homologous recombination deficiency test for epithelial ovarian cancer
by: Ying-Cheng Chiang, et al.
Published: (2025-01-01)

Near-infrared fluorescent molecular probes with cetuximab in the in vivo fluorescence imaging for epithelial ovarian cancer
by: Chen Zhang, et al.
Published: (2024-11-01)

Activin levels correlate with lymphocytic infiltration in epithelial ovarian cancer
by: Elizabeth T. Evans, et al.
Published: (2024-09-01)

Characterization of innate lymphoid cell subsets infiltrating melanoma and epithelial ovarian tumors
by: Douglas C. Chung, et al.
Published: (2024-12-01)

Promising new drugs and therapeutic approaches for treatment of ovarian cancer—targeting the hallmarks of cancer
by: Julia Hillmann, et al.
Published: (2025-01-01)

A Rare Case of Metachronous Clear Cell Ovarian Carcinoma and Thyroid Carcinoma: Clinical and Pathological Insights
by: Ridwan S, et al.
Published: (2025-01-01)

Jejunal Fistula Complicating Ovarian Serous Carcinoma: Case Report of a Rare Phenomenon and Review of the Literature
by: Isin Ureyen, et al.
Published: (2021-08-01)

The oncogenic roles of GPR176 in ovarian cancer: a molecular target for aggressiveness and gene therapy
by: Ning Yang, et al.
Published: (2024-12-01)

Incidence and risk factors of silent deep venous thromboembolism before interval debulking surgery in ovarian cancer patients, a tertiary centre experience
by: Mohamed Abdelkhalek, et al.
Published: (2024-12-01)

Clinical Outcomes of Poly(ADP–Ribose) Polymerase Inhibitors as Maintenance Therapy in Patients with Ovarian Cancer in the Southeastern Region of Korea
by: Hyeong In Ha, et al.
Published: (2024-10-01)

The dual edges of neoadjuvant chemotherapy in advanced epithelial ovarian cancer: Therapeutic potential and clinical dilemmas
by: Li Jia, et al.
Published: (2024-12-01)

The best ovarian reserve marker to predict ovarian response following controlled ovarian hyperstimulation: a systematic review and meta-analysis
by: Fateme Salemi, et al.
Published: (2024-12-01)

Proteome-Wide Mendelian Randomization Analysis to Identify Potential Plasma Biomarkers and Therapeutic Targets for Epithelial Ovarian Cancer Subtypes
by: Lin Q, et al.
Published: (2024-12-01)

Tumor biomarkers contribute to the diagnosis and clinical management of the O-RADS MRI risk stratification system for epithelial ovarian tumors
by: Shengjie Xu, et al.
Published: (2025-01-01)

Transcriptome Concordance Between Borderline Tumors and Endometrioid Carcinoma: An Integrative Genomic Analysis
by: Mio Takahashi, et al.
Published: (2025-01-01)

Development and validation of a deep learning pipeline to diagnose ovarian masses using ultrasound screening: a retrospective multicenter studyResearch in context
by: Wen-Li Dai, et al.
Published: (2024-12-01)

Targeting the SPC25/RIOK1/MYH9 Axis to Overcome Tumor Stemness and Platinum Resistance in Epithelial Ovarian Cancer
by: Xingyu Jiang, et al.
Published: (2024-12-01)

The administration of human amniotic epithelial cells in premature ovarian insufficiency: From preclinical to clinical
by: Xiaojing Zhao, et al.
Published: (2024-12-01)